Lacosamide
Generic name: Pronounced as (la koe' sa mide)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 01/15/2022
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Lacosamide is used to control partial onset seizures (seizures that involve only one part of the brain) in adults and children 1 month of age and older. Lacosamide is also used in combination with other medications to control primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 4 years of age and older. Lacosamide is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
How should this medicine be used?
Lacosamide comes as a tablet and as an solution (liquid) to take by mouth. It is usually taken twice a day with or without food. Take lacosamide at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take lacosamide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow the tablets whole; do not chew, split. or crush them.
If you are taking the oral solution, use a dose measuring spoon or oral syringe to measure the correct amount of liquid needed for each dose. Do not use a regular household spoon. If you have a nasogastric (NG) or gastric tube, your doctor or pharmacist will explain how to prepare lacosamide to administer it.
Your doctor will probably start you on a low dose of lacosamide and gradually increase your dose, not more often than once a week.
Lacosamide may help control your condition but will not cure it. It may take a few weeks or longer before you feel the full benefit of lacosamide. Continue to take lacosamide even if you feel well. Do not stop taking lacosamide without talking to your doctor, even if you experience side effects such as unusual changes in behavior or mood. If you suddenly stop taking lacosamide, your seizures may happen more often. Your doctor will probably decrease your dose gradually.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking lacosamide,
-
tell your doctor and pharmacist if you are allergic to lacosamide, any other medications, or any of the ingredients in lacosamide tablets or oral solution. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: beta blockers such as atenolol (Tenormin, in Tenoretic), labetalol (Trandate), metoprolol (Lopressor, Toprol XL), nadolol (Corgard), and propranolol (Hemangeol, Inderal); calcium channel blockers such as amlodipine (Norvasc, in Caduet, in Lotrel, in Exforge, others), diltiazem (Cardizem, Cartia, Tiazac, others), felodipine, isradipine, nicardipine, nifedipine (Procardia), nimodipine (Nymalize), nisoldipine (Sular), and verapamil (Calan, Verelan, in Tarka); and medications for irregular heartbeat such as amiodarone (Nexterone, Pacerone), digoxin (Lanoxin), dronedarone (Multaq), flecainide (Tambocor), propafenone (Rythmol), quinidine (in Nuedexta), and sotalol (Betapace, Sorine, Sotylize). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with lacosamide, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.
-
tell your doctor if you currently or have ever drunk large amounts of alcohol, used street drugs, or over-used prescription medications. Also tell your doctor if you have or have ever had depression, mood problems, suicidal thoughts or behavior; an irregular heartbeat, a heart attack, a pacemaker, heart failure, or other heart problems; diabetic neuropathy (nerve damage caused by diabetes); or liver or kidney disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking lacosamide, call your doctor.
-
you should know that lacosamide may make you dizzy or drowsy and may cause blurred vision or problems with coordination and balance. Do not drive a car, operate machinery, or participate in activities requiring alertness or coordination until you know how this medication affects you.
-
you should know that your mental health may change in unexpected ways and you may become suicidal (thinking about harming or killing yourself or planning or trying to do so) while you are taking lacosamide. A small number of adults and children 5 years of age and older (about 1 in 500 people) who took anticonvulsants like lacosamide to treat various conditions during clinical studies became suicidal during their treatment. Some of these people developed suicidal thoughts and behavior as early as 1 week after they started taking the medication. There is a risk that you may experience changes in your mental health if you take an anticonvulsant medication such as lacosamide, but there may also be a risk that you will experience changes in your mental health if your condition is not treated. You and your doctor will decide whether the risks of taking an anticonvulsant medication are greater than the risks of not taking the medication. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: panic attacks; agitation or restlessness; new or worsening irritability, anxiety, or depression; acting on dangerous impulses; difficulty falling asleep or staying asleep; aggressive, angry, or violent behavior; mania (frenzied, abnormally excited mood); talking or thinking about wanting to hurt yourself or end your life; or any other unusual changes in behavior or mood. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.
-
you should know that lacosamide may cause dizziness, lightheadedness, fainting, or irregular heartbeat, especially when you get up too quickly from a lying position. If you develop these symptoms, lie down with your legs raised until you feel better, and call your doctor right away.
-
if you have phenylketonuria (PKU, an inherited condition in which a special diet must be followed to prevent damage to your brain that can cause severe intellectual disability), you should know that lacosamide oral solution contains aspartame that forms phenylalanine.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Lacosamide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
nausea
-
vomiting
-
diarrhea
-
blurred or double vision
-
uncontrollable eye movements
-
dizziness
-
headache
-
drowsiness
-
uncontrollable shaking of a part of the body
-
problems with coordination, balance, or walking
-
weakness
-
itching
-
-
Some side effects can be serious. If you experience any of these symptoms, or those listed in the SPECIAL PRECAUTIONS section, call your doctor immediately:
-
fast or pounding heartbeat or pulse
-
shortness of breath
-
slow heartbeat
-
chest pain
-
fainting
-
swelling of the face, throat, tongue, lips, and eyes
-
fever
-
rash
-
tiredness
-
yellowing of the skin or eyes
-
dark urine
-
-
Lacosamide may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Do not freeze the oral solution. Discard any unused oral solution 6 months after first opening the bottle.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor.
Do not let anyone else take your medication. Lacosamide is a controlled substance. Prescriptions may be refilled only a limited number of times; ask your pharmacist if you have any questions.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Montelukast | Montelukast The metabolism of Lacosamide can be decreased when combined with Montelukast. |
Leflunomide | Leflunomide The metabolism of Lacosamide can be decreased when combined with Leflunomide. |
Delavirdine | Delavirdine The serum concentration of Lacosamide can be increased when it is combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Lacosamide can be decreased when combined with Nevirapine. |
Dolasetron | Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Lacosamide. |
Aminophylline | Aminophylline The metabolism of Aminophylline can be decreased when combined with Lacosamide. |
Candesartan | Candesartan The metabolism of Lacosamide can be decreased when combined with Candesartan. |
Clopidogrel | Clopidogrel The metabolism of Lacosamide can be decreased when combined with Clopidogrel. |
Diphenoxylate | Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Lacosamide. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The metabolism of Lacosamide can be decreased when combined with Erythromycin. |
Fenofibrate | Fenofibrate The metabolism of Lacosamide can be decreased when combined with Fenofibrate. |
Guanfacine | Guanfacine The risk or severity of adverse effects can be increased when Guanfacine is combined with Lacosamide. |
Methylergonovine | Methylergonovine The metabolism of Lacosamide can be decreased when combined with Methylergometrine. |
Naratriptan | Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Lacosamide. |
Paregoric | Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Lacosamide. |
Penbutolol | Penbutolol Acebutolol may increase the bradycardic activities of Lacosamide. |
Pentazocine | Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Lacosamide. |
Reserpine | Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Lacosamide. |
Rizatriptan | Rizatriptan The risk or severity of adverse effects can be increased when Rizatriptan is combined with Lacosamide. |
Sumatriptan | Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lacosamide. |
Tacrolimus | Tacrolimus The metabolism of Tacrolimus can be decreased when combined with Lacosamide. |
Tizanidine | Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Lacosamide. |
Triamcinolone | Triamcinolone The metabolism of Lacosamide can be increased when combined with Triamcinolone. |
Zolmitriptan | Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lacosamide. |
Doxycycline Injection | Doxycycline Injection The metabolism of Lacosamide can be decreased when combined with Doxycycline. |
Fluconazole Injection | Fluconazole Injection The metabolism of Lacosamide can be decreased when combined with Fluconazole. |
Hydromorphone Injection | Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lacosamide. |
Meperidine Injection | Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Lacosamide. |
Methylprednisolone Injection | Methylprednisolone Injection The metabolism of Lacosamide can be increased when combined with Methylprednisolone. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Lacosamide. |
Metronidazole Injection | Metronidazole Injection The metabolism of Lacosamide can be decreased when combined with Metronidazole. |
Morphine Injection | Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Lacosamide. |
Zidovudine Injection | Zidovudine Injection The metabolism of Lacosamide can be decreased when combined with Zidovudine. |
Altretamine | Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Lacosamide. |
Cyclosporine | Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Lacosamide. |
Ondansetron | Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Lacosamide. |
Granisetron | Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Lacosamide. |
Torsemide | Torsemide The metabolism of Lacosamide can be decreased when combined with Torasemide. |
Olanzapine | Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Lacosamide. |
Alosetron | Alosetron The risk or severity of adverse effects can be increased when Alosetron is combined with Lacosamide. |
Dofetilide | Dofetilide The metabolism of Dofetilide can be decreased when combined with Lacosamide. |
Entacapone | Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Lacosamide. |
Hydroxychloroquine | Hydroxychloroquine The therapeutic efficacy of Lacosamide can be decreased when used in combination with Hydroxychloroquine. |
Meloxicam | Meloxicam The metabolism of Lacosamide can be decreased when combined with Meloxicam. |
Orlistat | Orlistat Orlistat can cause a decrease in the absorption of Lacosamide resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Oxcarbazepine | Oxcarbazepine The metabolism of Lacosamide can be decreased when combined with Oxcarbazepine. |
Pantoprazole | Pantoprazole The metabolism of Lacosamide can be decreased when combined with Pantoprazole. |
Telmisartan | Telmisartan The metabolism of Lacosamide can be decreased when combined with Telmisartan. |
Zaleplon | Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Lacosamide. |
Anakinra | Anakinra The metabolism of Lacosamide can be increased when combined with Anakinra. |
Desloratadine | Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Lacosamide. |
Linezolid | Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Lacosamide. |
Rivastigmine | Rivastigmine Rivastigmine may increase the bradycardic activities of Lacosamide. |
Trimipramine | Trimipramine The metabolism of Lacosamide can be decreased when combined with Trimipramine. |
Etanercept Injection | Etanercept Injection The metabolism of Lacosamide can be increased when combined with Etanercept. |
Glycopyrrolate | Glycopyrrolate Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium. |
Modafinil | Modafinil The metabolism of Lacosamide can be decreased when combined with Modafinil. |
Tenofovir | Tenofovir The metabolism of Tenofovir can be decreased when combined with Lacosamide. |
Sirolimus | Sirolimus The metabolism of Sirolimus can be decreased when combined with Lacosamide. |
Epinephrine Injection | Epinephrine Injection The metabolism of Lacosamide can be decreased when combined with Epinephrine. |
Escitalopram | Escitalopram The risk or severity of adverse effects can be increased when Lacosamide is combined with Escitalopram. |
Zonisamide | Zonisamide The risk or severity of adverse effects can be increased when Zonisamide is combined with Lacosamide. |
Adalimumab Injection | Adalimumab Injection The metabolism of Lacosamide can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The risk or severity of adverse effects can be increased when Aripiprazole is combined with Lacosamide. |
Atomoxetine | Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Lacosamide. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of adverse effects can be increased when Lacosamide is combined with Dexmethylphenidate. |
Atazanavir | Atazanavir The metabolism of Lacosamide can be decreased when combined with Atazanavir. |
Almotriptan | Almotriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Lacosamide. |
Eletriptan | Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Lacosamide. |
Mefloquine | Mefloquine The therapeutic efficacy of Lacosamide can be decreased when used in combination with Mefloquine. |
Rosuvastatin | Rosuvastatin The metabolism of Lacosamide can be decreased when combined with Rosuvastatin. |
Aprepitant | Aprepitant The metabolism of Lacosamide can be decreased when combined with Aprepitant. |
Memantine | Memantine The metabolism of Lacosamide can be decreased when combined with Memantine. |
Frovatriptan | Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lacosamide. |
Progesterone | Progesterone The metabolism of Lacosamide can be increased when combined with Progesterone. |
Apomorphine Injection | Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Lacosamide. |
Infliximab Injection | Infliximab Injection The metabolism of Lacosamide can be increased when combined with Infliximab. |
Oxandrolone | Oxandrolone The metabolism of Lacosamide can be decreased when combined with Oxandrolone. |
Protriptyline | Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Lacosamide. |
Rifaximin | Rifaximin The metabolism of Lacosamide can be increased when combined with Rifaximin. |
Duloxetine | Duloxetine The risk or severity of adverse effects can be increased when Lacosamide is combined with Duloxetine. |
Norethindrone | Norethindrone The metabolism of Lacosamide can be increased when combined with Norethisterone. |
Trospium | Trospium Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Trospium. |
Bosentan | Bosentan The metabolism of Lacosamide can be increased when combined with Bosentan. |
Erlotinib | Erlotinib The metabolism of Lacosamide can be decreased when combined with Erlotinib. |
Eszopiclone | Eszopiclone The risk or severity of CNS depression can be increased when Lacosamide is combined with Eszopiclone. |
Ganciclovir | Ganciclovir The therapeutic efficacy of Lacosamide can be decreased when used in combination with Ganciclovir. |
Solifenacin | Solifenacin Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Solifenacin. |
Valganciclovir | Valganciclovir The therapeutic efficacy of Lacosamide can be decreased when used in combination with Valganciclovir. |
Voriconazole | Voriconazole The metabolism of Lacosamide can be decreased when combined with Voriconazole. |
Dextroamphetamine | Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Lacosamide. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The metabolism of Lacosamide can be increased when combined with Peginterferon alfa-2b. |
Sodium Oxybate | Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Isocarboxazid | Isocarboxazid The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Lacosamide. |
Ramelteon | Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Lacosamide. |
Darifenacin | Darifenacin Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Darifenacin. |
Fentanyl | Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Lacosamide. |
Pregabalin | Pregabalin The therapeutic efficacy of Lacosamide can be increased when used in combination with Pregabalin. |
Deferasirox | Deferasirox The metabolism of Lacosamide can be increased when combined with Deferasirox. |
Tipranavir | Tipranavir The metabolism of Tipranavir can be decreased when combined with Lacosamide. |
Felbamate | Felbamate The metabolism of Lacosamide can be decreased when combined with Felbamate. |
Ranolazine | Ranolazine The metabolism of Lacosamide can be decreased when combined with Ranolazine. |
Abatacept Injection | Abatacept Injection The metabolism of Lacosamide can be increased when combined with Abatacept. |
Rasagiline | Rasagiline The risk or severity of adverse effects can be increased when Rasagiline is combined with Lacosamide. |
Imatinib | Imatinib The metabolism of Lacosamide can be decreased when combined with Imatinib. |
Gefitinib | Gefitinib The metabolism of Lacosamide can be decreased when combined with Gefitinib. |
Paliperidone | Paliperidone The risk or severity of adverse effects can be increased when Paliperidone is combined with Lacosamide. |
Bortezomib | Bortezomib The metabolism of Lacosamide can be decreased when combined with Bortezomib. |
Posaconazole | Posaconazole The metabolism of Lacosamide can be decreased when combined with Posaconazole. |
Primaquine | Primaquine The metabolism of Lacosamide can be decreased when combined with Primaquine. |
Darunavir | Darunavir The metabolism of Darunavir can be decreased when combined with Lacosamide. |
Dimenhydrinate | Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Lacosamide. |
Nabilone | Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Sorafenib | Sorafenib The metabolism of Lacosamide can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The metabolism of Lacosamide can be decreased when combined with Sunitinib. |
Dronabinol | Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Lapatinib | Lapatinib The metabolism of Lacosamide can be decreased when combined with Lapatinib. |
Levocetirizine | Levocetirizine The risk or severity of adverse effects can be increased when Lacosamide is combined with Levocetirizine. |
Dasatinib | Dasatinib The metabolism of Dasatinib can be decreased when combined with Lacosamide. |
Armodafinil | Armodafinil The metabolism of Lacosamide can be decreased when combined with Armodafinil. |
Ivermectin | Ivermectin The metabolism of Lacosamide can be increased when combined with Ivermectin. |
Temsirolimus | Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Lacosamide. |
Nilotinib | Nilotinib The metabolism of Lacosamide can be decreased when combined with Nilotinib. |
Bexarotene | Bexarotene The metabolism of Lacosamide can be increased when combined with Bexarotene. |
Budesonide | Budesonide The metabolism of Lacosamide can be increased when combined with Budesonide. |
Chloramphenicol Injection | Chloramphenicol Injection The metabolism of Lacosamide can be decreased when combined with Chloramphenicol. |
OnabotulinumtoxinA Injection | OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Lacosamide. |
RimabotulinumtoxinB Injection | RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lacosamide. |
Etravirine | Etravirine The metabolism of Lacosamide can be decreased when combined with Etravirine. |
Mitoxantrone Injection | Mitoxantrone Injection The metabolism of Lacosamide can be decreased when combined with Mitoxantrone. |
Desvenlafaxine | Desvenlafaxine The risk or severity of adverse effects can be increased when Lacosamide is combined with Desvenlafaxine. |
Nebivolol | Nebivolol The metabolism of Lacosamide can be decreased when combined with Nebivolol. |
Tretinoin | Tretinoin The metabolism of Lacosamide can be decreased when combined with Tretinoin. |
Pilocarpine | Pilocarpine The metabolism of Lacosamide can be decreased when combined with Pilocarpine. |
Flecainide | Flecainide The metabolism of Lacosamide can be decreased when combined with Flecainide. |
Certolizumab Injection | Certolizumab Injection The metabolism of Lacosamide can be increased when combined with Certolizumab pegol. |
Ixabepilone Injection | Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Lacosamide. |
Irinotecan Injection | Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Lacosamide. |
Praziquantel | Praziquantel The metabolism of Lacosamide can be decreased when combined with Praziquantel. |
Mitotane | Mitotane The metabolism of Lacosamide can be increased when combined with Mitotane. |
Rufinamide | Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Lacosamide. |
Midazolam | Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Lacosamide. |
Milnacipran | Milnacipran The risk or severity of adverse effects can be increased when Lacosamide is combined with Milnacipran. |
Dexlansoprazole | Dexlansoprazole The metabolism of Lacosamide can be decreased when combined with Dexlansoprazole. |
Sodium Phosphate | Sodium Phosphate The therapeutic efficacy of Lacosamide can be decreased when used in combination with Sodium phosphate, monobasic. |
Fesoterodine | Fesoterodine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine. |
Betaxolol | Betaxolol Betaxolol may increase the bradycardic activities of Lacosamide. |
Iloperidone | Iloperidone The risk or severity of adverse effects can be increased when Iloperidone is combined with Lacosamide. |
Prasugrel | Prasugrel The metabolism of Lacosamide can be decreased when combined with Prasugrel. |
Everolimus | Everolimus The metabolism of Everolimus can be decreased when combined with Lacosamide. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Lacosamide. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Lacosamide. |
AbobotulinumtoxinA Injection | AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Lacosamide. |
Palonosetron Injection | Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Lacosamide. |
Romidepsin Injection | Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Lacosamide. |
Tapentadol | Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Topotecan | Topotecan Topotecan may increase the excretion rate of Lacosamide which could result in a lower serum level and potentially a reduction in efficacy. |
Golimumab Injection | Golimumab Injection The metabolism of Lacosamide can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Lacosamide. |
Asenapine | Asenapine The risk or severity of adverse effects can be increased when Asenapine is combined with Lacosamide. |
Vigabatrin | Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Lacosamide. |
Pitavastatin | Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Lacosamide. |
Albendazole | Albendazole The metabolism of Lacosamide can be decreased when combined with Albendazole. |
Ulipristal | Ulipristal The metabolism of Ulipristal can be increased when combined with Lacosamide. |
Levonorgestrel | Levonorgestrel The metabolism of Lacosamide can be increased when combined with Levonorgestrel. |
Oxymorphone | Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Lacosamide. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Lacosamide can be increased when combined with Tocilizumab. |
Fingolimod | Fingolimod Lacosamide may increase the bradycardic activities of Fingolimod. |
IncobotulinumtoxinA Injection | IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Lacosamide. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Lacosamide. |
Lurasidone | Lurasidone The risk or severity of adverse effects can be increased when Lacosamide is combined with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Lacosamide can be increased when combined with Acetaminophen. |
Vilazodone | Vilazodone The risk or severity of adverse effects can be increased when Lacosamide is combined with Vilazodone. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The metabolism of Lacosamide can be decreased when combined with Aldesleukin. |
Busulfan Injection | Busulfan Injection The metabolism of Busulfan can be decreased when combined with Lacosamide. |
Roflumilast | Roflumilast The metabolism of Lacosamide can be decreased when combined with Roflumilast. |
Linagliptin | Linagliptin The metabolism of Lacosamide can be decreased when combined with Linagliptin. |
Rilpivirine | Rilpivirine The metabolism of Lacosamide can be decreased when combined with Rilpivirine. |
Telaprevir | Telaprevir The metabolism of Lacosamide can be decreased when combined with Glecaprevir. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Lacosamide can be decreased when combined with Cyclophosphamide. |
Abiraterone | Abiraterone The metabolism of Lacosamide can be decreased when combined with Abiraterone. |
Ticagrelor | Ticagrelor The metabolism of Lacosamide can be decreased when combined with Ticagrelor. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The metabolism of Lacosamide can be decreased when combined with Brentuximab vedotin. |
Ruxolitinib | Ruxolitinib Ruxolitinib may increase the bradycardic activities of Lacosamide. |
Vandetanib | Vandetanib The metabolism of Vandetanib can be decreased when combined with Lacosamide. |
Clobazam | Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Lacosamide. |
Vemurafenib | Vemurafenib The metabolism of Lacosamide can be decreased when combined with Vemurafenib. |
Vismodegib | Vismodegib The metabolism of Lacosamide can be decreased when combined with Vismodegib. |
Ivacaftor | Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Lacosamide. |
Axitinib | Axitinib The metabolism of Axitinib can be decreased when combined with Lacosamide. |
Crizotinib | Crizotinib The metabolism of Lacosamide can be decreased when combined with Crizotinib. |
Cabergoline | Cabergoline The metabolism of Lacosamide can be decreased when combined with Cabergoline. |
Naloxone Injection | Naloxone Injection The metabolism of Lacosamide can be decreased when combined with Naloxone. |
Ezogabine | Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Lacosamide. |
Enzalutamide | Enzalutamide The metabolism of Lacosamide can be increased when combined with Enzalutamide. |
Regorafenib | Regorafenib The metabolism of Lacosamide can be decreased when combined with Regorafenib. |
Bosutinib | Bosutinib The metabolism of Lacosamide can be decreased when combined with Bosutinib. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The metabolism of Lacosamide can be increased when combined with Corticotropin. |
Cabozantinib (thyroid cancer) | Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Lacosamide. |
Tofacitinib | Tofacitinib Lacosamide may increase the bradycardic activities of Tofacitinib. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Lacosamide. |
Pomalidomide | Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Lacosamide. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Lacosamide can be decreased when combined with Trastuzumab emtansine. |
Apixaban | Apixaban The metabolism of Apixaban can be decreased when combined with Lacosamide. |
Dabrafenib | Dabrafenib The serum concentration of Lacosamide can be decreased when it is combined with Dabrafenib. |
Ospemifene | Ospemifene The metabolism of Lacosamide can be decreased when combined with Ospemifene. |
Trametinib | Trametinib The metabolism of Lacosamide can be increased when combined with Trametinib. |
Levomilnacipran | Levomilnacipran The risk or severity of adverse effects can be increased when Lacosamide is combined with Levomilnacipran. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Lacosamide. |
Perampanel | Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Lomitapide | Lomitapide The metabolism of Lacosamide can be decreased when combined with Lomitapide. |
Ketorolac Injection | Ketorolac Injection The metabolism of Lacosamide can be decreased when combined with Ketorolac. |
Simeprevir | Simeprevir The metabolism of Lacosamide can be decreased when combined with Simeprevir. |
Dapagliflozin | Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Lacosamide. |
Apremilast | Apremilast The metabolism of Lacosamide can be increased when combined with Apremilast. |
Ceritinib | Ceritinib Lacosamide may increase the bradycardic activities of Ceritinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Lacosamide can be increased when combined with Siltuximab. |
Eslicarbazepine | Eslicarbazepine The risk or severity of adverse effects can be increased when Lacosamide is combined with Eslicarbazepine. |
Idelalisib | Idelalisib The metabolism of Idelalisib can be decreased when combined with Lacosamide. |
Testosterone Injection | Testosterone Injection The metabolism of Lacosamide can be increased when combined with Testosterone. |
Oritavancin Injection | Oritavancin Injection The metabolism of Lacosamide can be decreased when combined with Oritavancin. |
Vorapaxar | Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Lacosamide. |
Hydrocodone | Hydrocodone Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
Suvorexant | Suvorexant Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Lacosamide. |
Methamphetamine | Methamphetamine The risk or severity of adverse effects can be increased when Metamfetamine is combined with Lacosamide. |
Tasimelteon | Tasimelteon The risk or severity of adverse effects can be increased when Lacosamide is combined with Tasimelteon. |
Lanreotide Injection | Lanreotide Injection Lacosamide may increase the bradycardic activities of Lanreotide. |
Nintedanib | Nintedanib The metabolism of Nintedanib can be decreased when combined with Lacosamide. |
Secukinumab Injection | Secukinumab Injection The metabolism of Lacosamide can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Lacosamide. |
Palbociclib | Palbociclib The metabolism of Palbociclib can be decreased when combined with Lacosamide. |
Lenvatinib | Lenvatinib The metabolism of Lacosamide can be decreased when combined with Lenvatinib. |
Naloxegol | Naloxegol The metabolism of Lacosamide can be decreased when combined with Naloxegol. |
Panobinostat | Panobinostat The metabolism of Panobinostat can be decreased when combined with Lacosamide. |
Haloperidol Injection | Haloperidol Injection The risk or severity of CNS depression can be increased when Haloperidol is combined with Lacosamide. |
Ivabradine | Ivabradine Lacosamide may increase the bradycardic activities of Ivabradine. |
Isavuconazonium Injection | Isavuconazonium Injection The metabolism of Lacosamide can be increased when combined with Isavuconazonium. |
Sonidegib | Sonidegib The metabolism of Sonidegib can be decreased when combined with Lacosamide. |
Flibanserin | Flibanserin The risk or severity of adverse effects can be increased when Flibanserin is combined with Lacosamide. |
Prednisolone | Prednisolone The metabolism of Lacosamide can be increased when combined with Prednisolone. |
Brexpiprazole | Brexpiprazole The risk or severity of adverse effects can be increased when Lacosamide is combined with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Lacosamide. |
Cariprazine | Cariprazine The risk or severity of adverse effects can be increased when Cariprazine is combined with Lacosamide. |
Cobimetinib | Cobimetinib The metabolism of Lacosamide can be decreased when combined with Cobimetinib. |
Trabectedin Injection | Trabectedin Injection The metabolism of Lacosamide can be decreased when combined with Trabectedin. |
Osimertinib | Osimertinib The metabolism of Lacosamide can be decreased when combined with Osimertinib. |
Alectinib | Alectinib The metabolism of Alectinib can be decreased when combined with Lacosamide. |
Ixazomib | Ixazomib The metabolism of Ixazomib can be decreased when combined with Lacosamide. |
Rifapentine | Rifapentine The metabolism of Lacosamide can be increased when combined with Rifapentine. |
Lesinurad | Lesinurad The metabolism of Lesinurad can be increased when combined with Lacosamide. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The metabolism of Lacosamide can be decreased when combined with Amphotericin B. |
Dexamethasone Injection | Dexamethasone Injection The metabolism of Lacosamide can be increased when combined with Dexamethasone. |
Brivaracetam Injection | Brivaracetam Injection The risk or severity of adverse effects can be increased when Brivaracetam is combined with Lacosamide. |
Venetoclax | Venetoclax The metabolism of Lacosamide can be decreased when combined with Venetoclax. |
Cobicistat | Cobicistat The metabolism of Lacosamide can be decreased when combined with Cobicistat. |
Midodrine | Midodrine Midodrine may increase the bradycardic activities of Lacosamide. |
Pimavanserin | Pimavanserin The risk or severity of adverse effects can be increased when Pimavanserin is combined with Lacosamide. |
Diphenhydramine Injection | Diphenhydramine Injection The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Lacosamide. |
Rucaparib | Rucaparib The metabolism of Lacosamide can be decreased when combined with Rucaparib. |
Ribociclib | Ribociclib The metabolism of Lacosamide can be decreased when combined with Ribociclib. |
Brigatinib | Brigatinib The metabolism of Lacosamide can be decreased when combined with Brigatinib. |
Doxepin (Insomnia) | Doxepin (Insomnia) Doxepin may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Deflazacort | Deflazacort The metabolism of Lacosamide can be increased when combined with Deflazacort. |
Safinamide | Safinamide The metabolism of Lacosamide can be decreased when combined with Safinamide. |
Sarilumab Injection | Sarilumab Injection The metabolism of Lacosamide can be increased when combined with Sarilumab. |
Midostaurin | Midostaurin The metabolism of Lacosamide can be increased when combined with Midostaurin. |
Neratinib | Neratinib The metabolism of Neratinib can be decreased when combined with Lacosamide. |
Enasidenib | Enasidenib The metabolism of Lacosamide can be decreased when combined with Enasidenib. |
Aprepitant/Fosaprepitant Injection | Aprepitant/Fosaprepitant Injection The metabolism of Lacosamide can be increased when combined with Fosaprepitant. |
Copanlisib Injection | Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Lacosamide. |
Delafloxacin | Delafloxacin The metabolism of Lacosamide can be increased when combined with Delafloxacin. |
Abemaciclib | Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Lacosamide. |
Acalabrutinib | Acalabrutinib The metabolism of Lacosamide can be decreased when combined with Acalabrutinib. |
Letermovir | Letermovir The metabolism of Lacosamide can be decreased when combined with Letermovir. |
Buprenorphine Injection | Buprenorphine Injection Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
Apalutamide | Apalutamide The serum concentration of Lacosamide can be increased when it is combined with Apalutamide. |
Fostamatinib | Fostamatinib The metabolism of Lacosamide can be decreased when combined with Fostamatinib. |
Avatrombopag | Avatrombopag The metabolism of Lacosamide can be increased when combined with Avatrombopag. |
Baricitinib | Baricitinib The metabolism of Baricitinib can be decreased when combined with Lacosamide. |
Lofexidine | Lofexidine The therapeutic efficacy of Lacosamide can be increased when used in combination with Lofexidine. |
Ivosidenib | Ivosidenib The metabolism of Lacosamide can be decreased when combined with Ivosidenib. |
Cannabidiol | Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lacosamide. |
Dacomitinib | Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Lacosamide. |
Duvelisib | Duvelisib The metabolism of Duvelisib can be decreased when combined with Lacosamide. |
Stiripentol | Stiripentol The metabolism of Lacosamide can be decreased when combined with Stiripentol. |
Gilteritinib | Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Lacosamide. |
Lorlatinib | Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Lacosamide. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Lacosamide. |
Rifamycin | Rifamycin The metabolism of Lacosamide can be increased when combined with Rifamycin. |
Prucalopride | Prucalopride The metabolism of Prucalopride can be decreased when combined with Lacosamide. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Lacosamide can be increased when combined with Emapalumab. |
Siponimod | Siponimod The metabolism of Siponimod can be decreased when combined with Lacosamide. |
Erdafitinib | Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Lacosamide. |
Esomeprazole Injection | Esomeprazole Injection The metabolism of Lacosamide can be decreased when combined with Esomeprazole. |
Alpelisib | Alpelisib The serum concentration of Lacosamide can be decreased when it is combined with Alpelisib. |
Brexanolone Injection | Brexanolone Injection The risk or severity of adverse effects can be increased when Lacosamide is combined with Brexanolone. |
Solriamfetol | Solriamfetol The risk or severity of adverse effects can be increased when Lacosamide is combined with Solriamfetol. |
Triclabendazole | Triclabendazole The metabolism of Lacosamide can be decreased when combined with Triclabendazole. |
Entrectinib | Entrectinib The metabolism of Entrectinib can be decreased when combined with Lacosamide. |
Pexidartinib | Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Lacosamide. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Lacosamide. |
Pitolisant | Pitolisant The serum concentration of Lacosamide can be decreased when it is combined with Pitolisant. |
Fedratinib | Fedratinib The metabolism of Fedratinib can be decreased when combined with Lacosamide. |
Lefamulin | Lefamulin The metabolism of Lefamulin can be decreased when combined with Lacosamide. |
Phenytoin Injection | Phenytoin Injection The serum concentration of Lacosamide can be decreased when it is combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The serum concentration of Lacosamide can be decreased when it is combined with Fosphenytoin. |
Zanubrutinib | Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Lacosamide. |
Voxelotor | Voxelotor The metabolism of Voxelotor can be decreased when combined with Lacosamide. |
Avapritinib | Avapritinib The metabolism of Avapritinib can be decreased when combined with Lacosamide. |
Lumateperone | Lumateperone The risk or severity of adverse effects can be increased when Lumateperone is combined with Lacosamide. |
Lasmiditan | Lasmiditan The risk or severity of adverse effects can be increased when Lacosamide is combined with Lasmiditan. |
Tazemetostat | Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Lacosamide. |
Cenobamate | Cenobamate The serum concentration of Lacosamide can be decreased when it is combined with Cenobamate. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be decreased when combined with Lacosamide. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Lacosamide. |
Lemborexant | Lemborexant The risk or severity of adverse effects can be increased when Lacosamide is combined with Lemborexant. |
Fenfluramine | Fenfluramine The risk or severity of adverse effects can be increased when Fenfluramine is combined with Lacosamide. |
Octreotide | Octreotide The serum concentration of the active metabolites of Lacosamide can be increased when Lacosamide is used in combination with Octreotide. |
Pralsetinib | Pralsetinib The metabolism of Lacosamide can be increased when combined with Pralsetinib. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Lacosamide can be decreased when it is combined with Satralizumab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Lacosamide can be increased when combined with Drospirenone. |
Viloxazine | Viloxazine The risk or severity of adverse effects can be increased when Lacosamide is combined with Viloxazine. |
Vitamin E (Alpha-Tocopherol) | Vitamin E (Alpha-Tocopherol) The metabolism of Lacosamide can be increased when combined with Vitamin E. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Lacosamide. |
Indomethacin | Indomethacin The metabolism of Lacosamide can be decreased when combined with Indomethacin. |
Mefenamic Acid | Mefenamic Acid The metabolism of Lacosamide can be decreased when combined with Mefenamic acid. |
Naproxen | Naproxen The metabolism of Lacosamide can be decreased when combined with Naproxen. |
Trazodone | Trazodone The risk or severity of adverse effects can be increased when Lacosamide is combined with Trazodone. |
Floxuridine | Floxuridine The metabolism of Lacosamide can be decreased when combined with Floxuridine. |
Phenobarbital | Phenobarbital The metabolism of Lacosamide can be increased when combined with Phenobarbital. |
Metaxalone | Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Lacosamide. |
Methotrexate Injection | Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Lacosamide. |
Levorphanol | Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Lacosamide. |
Primidone | Primidone The metabolism of Lacosamide can be increased when combined with Primidone. |
Methsuximide | Methsuximide The risk or severity of adverse effects can be increased when Methsuximide is combined with Lacosamide. |
Diethylpropion | Diethylpropion The risk or severity of adverse effects can be increased when Diethylpropion is combined with Lacosamide. |
Chlorpromazine | Chlorpromazine The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Lacosamide. |
Diazepam | Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Lacosamide. |
Oxazepam | Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Lacosamide. |
Flurazepam | Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Lacosamide. |
Clorazepate | Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Lacosamide. |
Lorazepam | Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Lacosamide. |
Codeine | Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Lacosamide. |
Meprobamate | Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Lacosamide. |
Chlordiazepoxide | Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Lacosamide. |
Bromocriptine | Bromocriptine The risk or severity of adverse effects can be increased when Bromocriptine is combined with Lacosamide. |
Tranylcypromine | Tranylcypromine The metabolism of Lacosamide can be decreased when combined with Tranylcypromine. |
Phenelzine | Phenelzine The metabolism of Lacosamide can be decreased when combined with Phenelzine. |
Procarbazine | Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Lacosamide. |
Ergoloid Mesylates | Ergoloid Mesylates The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lacosamide. |
Tetracycline | Tetracycline The metabolism of Lacosamide can be decreased when combined with Tetracycline. |
Minocycline | Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Prochlorperazine | Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Lacosamide. |
Thioridazine | Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Lacosamide. |
Trifluoperazine | Trifluoperazine The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Lacosamide. |
Dapsone | Dapsone The metabolism of Lacosamide can be decreased when combined with Dapsone. |
Sulfadiazine | Sulfadiazine The metabolism of Lacosamide can be decreased when combined with Sulfadiazine. |
Oxycodone | Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Lacosamide. |
Methadone | Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Lacosamide. |
Oxybutynin | Oxybutynin The metabolism of Lacosamide can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Maprotiline | Maprotiline Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Maprotiline. |
Ibuprofen | Ibuprofen The metabolism of Lacosamide can be decreased when combined with Ibuprofen. |
Trihexyphenidyl | Trihexyphenidyl Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl. |
Orphenadrine | Orphenadrine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
Perphenazine | Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Lacosamide. |
Fluphenazine | Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lacosamide. |
Phentermine | Phentermine The metabolism of Lacosamide can be decreased when combined with Phentermine. |
Methylphenidate | Methylphenidate The therapeutic efficacy of Lacosamide can be decreased when used in combination with Methylphenidate. |
Amoxapine | Amoxapine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Amoxapine. |
Hydrocortisone | Hydrocortisone The metabolism of Lacosamide can be increased when combined with Hydrocortisone. |
Doxorubicin | Doxorubicin The metabolism of Lacosamide can be decreased when combined with Doxorubicin. |
Carbamazepine | Carbamazepine The serum concentration of Lacosamide can be decreased when it is combined with Carbamazepine. |
Molindone | Molindone The risk or severity of adverse effects can be increased when Molindone is combined with Lacosamide. |
Methyldopa | Methyldopa Methyldopa may increase the bradycardic activities of Lacosamide. |
Clonidine | Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Lacosamide. |
Hydralazine | Hydralazine The metabolism of Lacosamide can be decreased when combined with Hydralazine. |
Cimetidine | Cimetidine The metabolism of Lacosamide can be decreased when combined with Cimetidine. |
Warfarin | Warfarin The metabolism of Warfarin can be decreased when combined with Lacosamide. |
Clonazepam | Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Lacosamide. |
Loperamide | Loperamide The metabolism of Lacosamide can be decreased when combined with Loperamide. |
Promethazine | Promethazine The risk or severity of adverse effects can be increased when Promethazine is combined with Lacosamide. |
Daunorubicin | Daunorubicin The metabolism of Lacosamide can be decreased when combined with Daunorubicin. |
Griseofulvin | Griseofulvin The metabolism of Lacosamide can be increased when combined with Griseofulvin. |
Digoxin | Digoxin Digoxin may increase the bradycardic activities of Lacosamide. |
Loxapine | Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Lacosamide. |
Chloroquine | Chloroquine The therapeutic efficacy of Lacosamide can be decreased when used in combination with Chloroquine. |
Quinine | Quinine The metabolism of Lacosamide can be decreased when combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Lacosamide. |
Calcitriol | Calcitriol The metabolism of Lacosamide can be increased when combined with Calcitriol. |
Sulfinpyrazone | Sulfinpyrazone The metabolism of Lacosamide can be decreased when combined with Sulfinpyrazone. |
Isosorbide | Isosorbide The metabolism of Isosorbide can be increased when combined with Lacosamide. |
Secobarbital | Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Lacosamide. |
Desipramine | Desipramine Desipramine may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Amitriptyline | Amitriptyline Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Imipramine | Imipramine The metabolism of Imipramine can be decreased when combined with Lacosamide. |
Probenecid | Probenecid The metabolism of Lacosamide can be decreased when combined with Probenecid. |
Quinidine | Quinidine The metabolism of Quinidine can be decreased when combined with Lacosamide. |
Isoniazid | Isoniazid The metabolism of Lacosamide can be decreased when combined with Isoniazid. |
Rifampin | Rifampin The metabolism of Rifampicin can be increased when combined with Lacosamide. |
Disopyramide | Disopyramide Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Disopyramide. |
Valproic Acid | Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Lacosamide. |
Tamoxifen | Tamoxifen The metabolism of Lacosamide can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Lacosamide. |
Methimazole | Methimazole The metabolism of Lacosamide can be decreased when combined with Methimazole. |
Chlorpropamide | Chlorpropamide The metabolism of Lacosamide can be decreased when combined with Chlorpropamide. |
Tolbutamide | Tolbutamide The metabolism of Lacosamide can be decreased when combined with Tolbutamide. |
Tolazamide | Tolazamide The metabolism of Lacosamide can be decreased when combined with Tolazamide. |
Dextromethorphan | Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Lacosamide. |
Cyclobenzaprine | Cyclobenzaprine The risk or severity of CNS depression can be increased when Lacosamide is combined with Cyclobenzaprine. |
Niacin | Niacin The metabolism of Lacosamide can be decreased when combined with Niacin. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Lacosamide. |
Doxylamine | Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Cyproheptadine | Cyproheptadine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine. |
Clemastine | Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Lacosamide. |
Chlorpheniramine | Chlorpheniramine The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Lacosamide. |
Brompheniramine | Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Lacosamide. |
Meclizine | Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Lacosamide. |
Dantrolene | Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Lacosamide. |
Chlorzoxazone | Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Lacosamide. |
Carisoprodol | Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Lacosamide. |
Methocarbamol | Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Lacosamide. |
Danazol | Danazol The metabolism of Lacosamide can be decreased when combined with Danazol. |
Disulfiram | Disulfiram The therapeutic efficacy of Lacosamide can be decreased when used in combination with Disulfiram. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The metabolism of Lacosamide can be decreased when combined with Propranolol. |
Nortriptyline | Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Lacosamide. |
Amphotericin B Injection | Amphotericin B Injection The metabolism of Lacosamide can be decreased when combined with Amphotericin B. |
Mercaptopurine | Mercaptopurine Lacosamide may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy. |
Nadolol | Nadolol Nadolol may increase the bradycardic activities of Lacosamide. |
Butorphanol Injection | Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Lacosamide. |
Nalbuphine Injection | Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lacosamide. |
Trimethobenzamide | Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Lacosamide. |
Flavoxate | Flavoxate Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Flavoxate. |
Fluorouracil Injection | Fluorouracil Injection The metabolism of Lacosamide can be decreased when combined with Fluorouracil. |
Colchicine | Colchicine The metabolism of Lacosamide can be increased when combined with Colchicine. |
Cephalexin | Cephalexin The metabolism of Lacosamide can be decreased when combined with Cephalexin. |
Acetazolamide | Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Lacosamide. |
Cefotaxime Injection | Cefotaxime Injection The therapeutic efficacy of Lacosamide can be decreased when used in combination with Cefotaxime. |
Ketoconazole | Ketoconazole The metabolism of Lacosamide can be decreased when combined with Ketoconazole. |
Pyrantel | Pyrantel The risk or severity of adverse effects can be increased when Lacosamide is combined with Pyrantel. |
Thiotepa Injection | Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Lacosamide. |
Vincristine Injection | Vincristine Injection The metabolism of Vincristine can be decreased when combined with Lacosamide. |
Vinblastine | Vinblastine The metabolism of Lacosamide can be decreased when combined with Vinblastine. |
Metoprolol | Metoprolol The metabolism of Lacosamide can be decreased when combined with Metoprolol. |
Hydroxyzine | Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Thiothixene | Thiothixene The risk or severity of adverse effects can be increased when Thiothixene is combined with Lacosamide. |
Aspirin | Aspirin The metabolism of Lacosamide can be decreased when combined with Acetylsalicylic acid. |
Chlorambucil | Chlorambucil The therapeutic efficacy of Lacosamide can be decreased when used in combination with Chlorambucil. |
Alprazolam | Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Lacosamide. |
Temazepam | Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Lacosamide. |
Triazolam | Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Lacosamide. |
Dicyclomine | Dicyclomine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine. |
Hyoscyamine | Hyoscyamine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine. |
Propantheline | Propantheline Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Propantheline. |
Trimethoprim | Trimethoprim The metabolism of Lacosamide can be decreased when combined with Trimethoprim. |
Diltiazem | Diltiazem The metabolism of Lacosamide can be decreased when combined with Diltiazem. |
Nifedipine | Nifedipine The metabolism of Lacosamide can be increased when combined with Nifedipine. |
Timolol | Timolol The metabolism of Lacosamide can be decreased when combined with Timolol. |
Verapamil | Verapamil The metabolism of Lacosamide can be decreased when combined with Verapamil. |
Atenolol | Atenolol Atenolol may increase the bradycardic activities of Lacosamide. |
Pindolol | Pindolol The risk or severity of adverse effects can be increased when Pindolol is combined with Lacosamide. |
Cisplatin Injection | Cisplatin Injection The metabolism of Lacosamide can be decreased when combined with Cisplatin. |
Piroxicam | Piroxicam The metabolism of Lacosamide can be decreased when combined with Piroxicam. |
Etoposide | Etoposide The metabolism of Lacosamide can be decreased when combined with Etoposide. |
Glyburide | Glyburide The metabolism of Lacosamide can be decreased when combined with Glyburide. |
Glipizide | Glipizide The metabolism of Lacosamide can be decreased when combined with Glipizide. |
Dicloxacillin | Dicloxacillin The metabolism of Lacosamide can be increased when combined with Dicloxacillin. |
Nafcillin Injection | Nafcillin Injection The metabolism of Lacosamide can be increased when combined with Nafcillin. |
Pentoxifylline | Pentoxifylline Lacosamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy. |
Labetalol | Labetalol The metabolism of Lacosamide can be decreased when combined with Labetalol. |
Gemfibrozil | Gemfibrozil The metabolism of Lacosamide can be decreased when combined with Gemfibrozil. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Lacosamide. |
Flurbiprofen | Flurbiprofen The metabolism of Lacosamide can be decreased when combined with Flurbiprofen. |
Amiodarone | Amiodarone The metabolism of Amiodarone can be decreased when combined with Lacosamide. |
Lovastatin | Lovastatin The metabolism of Lacosamide can be decreased when combined with Lovastatin. |
Ciprofloxacin | Ciprofloxacin The metabolism of Lacosamide can be decreased when combined with Ciprofloxacin. |
Diclofenac | Diclofenac The metabolism of Lacosamide can be decreased when combined with Diclofenac. |
Fluoxetine | Fluoxetine Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Lacosamide. |
Nimodipine | Nimodipine Nimodipine may increase the bradycardic activities of Lacosamide. |
Clozapine | Clozapine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Clozapine. |
Estazolam | Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Lacosamide. |
Idarubicin | Idarubicin The metabolism of Lacosamide can be decreased when combined with Idarubicin. |
Clarithromycin | Clarithromycin The metabolism of Lacosamide can be decreased when combined with Clarithromycin. |
Etodolac | Etodolac The metabolism of Lacosamide can be decreased when combined with Etodolac. |
Felodipine | Felodipine The metabolism of Lacosamide can be decreased when combined with Felodipine. |
Nabumetone | Nabumetone The metabolism of Lacosamide can be decreased when combined with Nabumetone. |
Simvastatin | Simvastatin The metabolism of Lacosamide can be decreased when combined with Simvastatin. |
Amlodipine | Amlodipine Amlodipine may increase the bradycardic activities of Lacosamide. |
Teniposide Injection | Teniposide Injection The metabolism of Lacosamide can be decreased when combined with Teniposide. |
Itraconazole | Itraconazole The metabolism of Lacosamide can be decreased when combined with Itraconazole. |
Atovaquone | Atovaquone The metabolism of Lacosamide can be decreased when combined with Atovaquone. |
Rifabutin | Rifabutin The metabolism of Lacosamide can be increased when combined with Rifabutin. |
Sotalol | Sotalol Sotalol may increase the bradycardic activities of Lacosamide. |
Bisoprolol | Bisoprolol Bisoprolol may increase the bradycardic activities of Lacosamide. |
Zolpidem | Zolpidem Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
Doxazosin | Doxazosin The metabolism of Lacosamide can be decreased when combined with Doxazosin. |
Isradipine | Isradipine The metabolism of Lacosamide can be decreased when combined with Isradipine. |
Omeprazole | Omeprazole The metabolism of Lacosamide can be decreased when combined with Omeprazole. |
Cisapride | Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Lacosamide. |
Gabapentin | Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Lacosamide. |
Fluvastatin | Fluvastatin The metabolism of Lacosamide can be decreased when combined with Fluvastatin. |
Venlafaxine | Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lacosamide. |
Famciclovir | Famciclovir The metabolism of Lacosamide can be decreased when combined with Famciclovir. |
Fluvoxamine | Fluvoxamine The metabolism of Lacosamide can be decreased when combined with Fluvoxamine. |
Nefazodone | Nefazodone The metabolism of Lacosamide can be decreased when combined with Nefazodone. |
Lamotrigine | Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Lacosamide. |
Losartan | Losartan The metabolism of Lacosamide can be decreased when combined with Losartan. |
Tramadol | Tramadol The risk or severity of CNS depression can be increased when Lacosamide is combined with Tramadol. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Lacosamide. |
Lansoprazole | Lansoprazole The metabolism of Lacosamide can be decreased when combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Lacosamide can be decreased when combined with Ifosfamide. |
Nicardipine | Nicardipine The metabolism of Lacosamide can be decreased when combined with Nicardipine. |
Bupropion | Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Lacosamide. |
Ticlopidine | Ticlopidine The metabolism of Lacosamide can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir The metabolism of Saquinavir can be decreased when combined with Lacosamide. |
Nisoldipine | Nisoldipine Nisoldipine may increase the bradycardic activities of Lacosamide. |
Riluzole | Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Lacosamide. |
Glimepiride | Glimepiride The metabolism of Lacosamide can be decreased when combined with Glimepiride. |
Ritonavir | Ritonavir The serum concentration of Lacosamide can be increased when it is combined with Ritonavir. |
Docetaxel Injection | Docetaxel Injection The metabolism of Lacosamide can be decreased when combined with Docetaxel. |
Clomipramine | Clomipramine The metabolism of Clomipramine can be decreased when combined with Lacosamide. |
Zafirlukast | Zafirlukast The metabolism of Lacosamide can be decreased when combined with Zafirlukast. |
Mirtazapine | Mirtazapine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
Topiramate | Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Lacosamide. |
Zileuton | Zileuton The metabolism of Lacosamide can be decreased when combined with Zileuton. |
Valsartan | Valsartan The metabolism of Lacosamide can be decreased when combined with Valsartan. |
Pramipexole | Pramipexole Lacosamide may increase the sedative activities of Pramipexole. |
Donepezil | Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Lacosamide. |
Nelfinavir | Nelfinavir The metabolism of Lacosamide can be decreased when combined with Nelfinavir. |
Azithromycin | Azithromycin The metabolism of Lacosamide can be decreased when combined with Azithromycin. |
Carvedilol | Carvedilol Carvedilol may increase the bradycardic activities of Lacosamide. |
Nilutamide | Nilutamide The metabolism of Lacosamide can be decreased when combined with Nilutamide. |
Selegiline | Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Lacosamide. |
Bicalutamide | Bicalutamide The metabolism of Lacosamide can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline The risk or severity of adverse effects can be increased when Lacosamide is combined with Sertraline. |
Propafenone | Propafenone Propafenone may increase the bradycardic activities of Lacosamide. |
Letrozole | Letrozole The metabolism of Lacosamide can be decreased when combined with Letrozole. |
Raloxifene | Raloxifene The metabolism of Lacosamide can be decreased when combined with Raloxifene. |
Irbesartan | Irbesartan The metabolism of Lacosamide can be decreased when combined with Irbesartan. |
Ropinirole | Ropinirole Lacosamide may increase the sedative activities of Ropinirole. |
Quetiapine | Quetiapine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine. |
Cetirizine | Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Lacosamide. |
Paroxetine | Paroxetine The risk or severity of adverse effects can be increased when Lacosamide is combined with Paroxetine. |
Tolcapone | Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Lacosamide. |
Citalopram | Citalopram The risk or severity of adverse effects can be increased when Lacosamide is combined with Citalopram. |
Capecitabine | Capecitabine The metabolism of Lacosamide can be decreased when combined with Capecitabine. |
Efavirenz | Efavirenz The metabolism of Lacosamide can be decreased when combined with Efavirenz. |
Sildenafil | Sildenafil The metabolism of Lacosamide can be decreased when combined with Sildenafil. |
Celecoxib | Celecoxib The metabolism of Lacosamide can be decreased when combined with Celecoxib. |
Rosiglitazone | Rosiglitazone The metabolism of Lacosamide can be decreased when combined with Rosiglitazone. |
Tolterodine | Tolterodine Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Tolterodine. |
Thalidomide | Thalidomide Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
Nateglinide | Nateglinide The metabolism of Lacosamide can be decreased when combined with Nateglinide. |
Galantamine | Galantamine Galantamine may increase the bradycardic activities of Lacosamide. |
Levetiracetam | Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Lacosamide. |
Rabeprazole | Rabeprazole The metabolism of Lacosamide can be decreased when combined with Rabeprazole. |
Terbinafine | Terbinafine The metabolism of Lacosamide can be increased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists